| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SP3 SP4 POU6F2 ZNF354A PKNOX1 POU2F1 CHD7 ZNF236 ZNF853 NFAT5 AR ZBTB24 | 2.21e-05 | 1244 | 47 | 12 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SP3 SP4 POU6F2 ZNF354A PKNOX1 POU2F1 CHD7 ZNF236 ZNF853 NFAT5 AR ZBTB24 | 2.73e-05 | 1271 | 47 | 12 | GO:0000987 |
| GeneOntologyMolecularFunction | chromatin binding | 4.78e-05 | 739 | 47 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SP3 SP4 POU6F2 ZNF354A PKNOX1 POU2F1 CHD7 ZNF236 ZNF853 NFAT5 AR ZBTB24 | 1.05e-04 | 1459 | 47 | 12 | GO:0000977 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.25e-04 | 127 | 47 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SP3 SP4 POU6F2 ZNF354A PKNOX1 POU2F1 ZNF236 ZNF853 NFAT5 AR ZBTB24 | 3.46e-04 | 1412 | 47 | 11 | GO:0000981 |
| Domain | LRR_8 | 4.81e-06 | 171 | 48 | 6 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 5.87e-06 | 177 | 48 | 6 | IPR003591 | |
| Domain | LRR_TYP | 5.87e-06 | 177 | 48 | 6 | SM00369 | |
| Domain | LRR | 1.21e-05 | 201 | 48 | 6 | PS51450 | |
| Domain | Ago_hook | 1.94e-05 | 3 | 48 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 1.94e-05 | 3 | 48 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 1.94e-05 | 3 | 48 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 1.94e-05 | 3 | 48 | 2 | PF16608 | |
| Domain | LRR_1 | 1.97e-05 | 219 | 48 | 6 | PF00560 | |
| Domain | LRRC37AB_C | 3.87e-05 | 4 | 48 | 2 | PF14914 | |
| Domain | LRRC37_N | 3.87e-05 | 4 | 48 | 2 | IPR032754 | |
| Domain | LRRC37AB_C | 3.87e-05 | 4 | 48 | 2 | IPR029423 | |
| Domain | LRRC37 | 3.87e-05 | 4 | 48 | 2 | PF15779 | |
| Domain | LRRC37A/B-like | 3.87e-05 | 4 | 48 | 2 | IPR015753 | |
| Domain | Leu-rich_rpt | 6.50e-05 | 271 | 48 | 6 | IPR001611 | |
| Domain | BRK | 9.64e-05 | 6 | 48 | 2 | SM00592 | |
| Domain | BRK_domain | 9.64e-05 | 6 | 48 | 2 | IPR006576 | |
| Domain | BRK | 9.64e-05 | 6 | 48 | 2 | PF07533 | |
| Domain | - | 1.64e-04 | 321 | 48 | 6 | 3.80.10.10 | |
| Domain | L_dom-like | 1.85e-04 | 328 | 48 | 6 | IPR032675 | |
| Domain | Sp1_fam | 2.87e-04 | 10 | 48 | 2 | IPR030450 | |
| Domain | UBA-like | 5.95e-04 | 64 | 48 | 3 | IPR009060 | |
| Domain | POU | 7.58e-04 | 16 | 48 | 2 | SM00352 | |
| Domain | POU_2 | 7.58e-04 | 16 | 48 | 2 | PS00465 | |
| Domain | POU_dom | 7.58e-04 | 16 | 48 | 2 | IPR000327 | |
| Domain | POU_3 | 7.58e-04 | 16 | 48 | 2 | PS51179 | |
| Domain | Pou | 7.58e-04 | 16 | 48 | 2 | PF00157 | |
| Domain | POU_1 | 7.58e-04 | 16 | 48 | 2 | PS00035 | |
| Domain | POU | 8.58e-04 | 17 | 48 | 2 | IPR013847 | |
| Domain | Chromo_domain | 1.72e-03 | 24 | 48 | 2 | IPR023780 | |
| Domain | Chromo | 2.02e-03 | 26 | 48 | 2 | PF00385 | |
| Domain | - | 2.18e-03 | 27 | 48 | 2 | 1.10.260.40 | |
| Domain | CHROMO_1 | 2.34e-03 | 28 | 48 | 2 | PS00598 | |
| Domain | CHROMO_2 | 2.34e-03 | 28 | 48 | 2 | PS50013 | |
| Domain | Lambda_DNA-bd_dom | 2.51e-03 | 29 | 48 | 2 | IPR010982 | |
| Domain | SNF2_N | 3.05e-03 | 32 | 48 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 3.05e-03 | 32 | 48 | 2 | IPR016197 | |
| Domain | SNF2_N | 3.05e-03 | 32 | 48 | 2 | PF00176 | |
| Domain | Chromo/shadow_dom | 3.25e-03 | 33 | 48 | 2 | IPR000953 | |
| Domain | CHROMO | 3.25e-03 | 33 | 48 | 2 | SM00298 | |
| Domain | - | 5.95e-03 | 283 | 48 | 4 | 1.10.10.60 | |
| Domain | - | 7.56e-03 | 679 | 48 | 6 | 3.30.160.60 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 9.45e-05 | 6 | 36 | 2 | MM15083 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 9.46e-05 | 35 | 36 | 3 | M27190 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.32e-04 | 7 | 36 | 2 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 2.26e-04 | 9 | 36 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 2.26e-04 | 9 | 36 | 2 | M46436 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.60e-04 | 49 | 36 | 3 | MM14837 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 2.82e-04 | 10 | 36 | 2 | M48013 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 4.12e-04 | 12 | 36 | 2 | M47628 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 4.86e-04 | 13 | 36 | 2 | M46434 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 8.42e-04 | 17 | 36 | 2 | M27788 | |
| Pathway | REACTOME_SUMOYLATION | 8.71e-04 | 169 | 36 | 4 | MM14919 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.06e-03 | 19 | 36 | 2 | M48238 | |
| Pathway | REACTOME_SUMOYLATION | 1.32e-03 | 189 | 36 | 4 | M27214 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 29791863 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20670374 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26560244 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30649323 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19058140 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 1454515 | ||
| Pubmed | GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells. | 2.11e-06 | 2 | 51 | 2 | 33038264 | |
| Pubmed | 2.53e-06 | 418 | 51 | 7 | 34709266 | ||
| Pubmed | 4.49e-06 | 22 | 51 | 3 | 31839203 | ||
| Pubmed | 5.97e-06 | 80 | 51 | 4 | 35803934 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 6.16e-06 | 908 | 51 | 9 | 19274049 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23540600 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26967243 | ||
| Pubmed | Curcumin decreases specificity protein expression in bladder cancer cells. | 6.32e-06 | 3 | 51 | 2 | 18593936 | |
| Pubmed | Transcriptional regulation of the mouse gene encoding the alpha-4 subunit of the GABAA receptor. | 6.32e-06 | 3 | 51 | 2 | 15265862 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 33277366 | ||
| Pubmed | Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. | 6.32e-06 | 3 | 51 | 2 | 11532028 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 24735383 | ||
| Pubmed | Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone. | 6.32e-06 | 3 | 51 | 2 | 18599544 | |
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 6.32e-06 | 3 | 51 | 2 | 34108231 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 25268761 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21919647 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26431879 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16880270 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 31670606 | ||
| Pubmed | Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. | 6.32e-06 | 3 | 51 | 2 | 7559627 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15781457 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 22419166 | ||
| Pubmed | Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct. | 1.26e-05 | 4 | 51 | 2 | 11997177 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 27889927 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 16574784 | ||
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 1.26e-05 | 4 | 51 | 2 | 21063388 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15138251 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 11096094 | ||
| Pubmed | 1.40e-05 | 209 | 51 | 5 | 36779422 | ||
| Pubmed | 2.00e-05 | 225 | 51 | 5 | 12168954 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 20538607 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 10547281 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 16037382 | ||
| Pubmed | Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis. | 2.10e-05 | 5 | 51 | 2 | 25802280 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 12560508 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 12771153 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 16061936 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 2.48e-05 | 824 | 51 | 8 | 20237496 | |
| Pubmed | 2.86e-05 | 407 | 51 | 6 | 12693553 | ||
| Pubmed | Critical involvement of RQCD1 in the EGFR-Akt pathway in mammary carcinogenesis. | 3.15e-05 | 6 | 51 | 2 | 20878056 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 17332529 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 18348986 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 7800480 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 16201967 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 3.86e-05 | 877 | 51 | 8 | 20211142 | |
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 4.41e-05 | 7 | 51 | 2 | 19470757 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 12004059 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 19383768 | ||
| Pubmed | 7.44e-05 | 963 | 51 | 8 | 28671696 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 10480874 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 23064749 | ||
| Pubmed | 1.13e-04 | 169 | 51 | 4 | 31462741 | ||
| Pubmed | Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase. | 1.15e-04 | 11 | 51 | 2 | 12943985 | |
| Pubmed | 1.48e-04 | 549 | 51 | 6 | 38280479 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.56e-04 | 184 | 51 | 4 | 32908313 | |
| Pubmed | 1.69e-04 | 808 | 51 | 7 | 20412781 | ||
| Pubmed | Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. | 1.90e-04 | 14 | 51 | 2 | 19716330 | |
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 12393188 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 2.19e-04 | 15 | 51 | 2 | 21981923 | |
| Pubmed | Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice. | 2.50e-04 | 16 | 51 | 2 | 30979723 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.57e-04 | 608 | 51 | 6 | 36089195 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.82e-04 | 1489 | 51 | 9 | 28611215 | |
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 21779181 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 3.18e-04 | 18 | 51 | 2 | 25363768 | |
| Pubmed | 3.89e-04 | 234 | 51 | 4 | 36243803 | ||
| Pubmed | 3.94e-04 | 20 | 51 | 2 | 11707078 | ||
| Pubmed | 4.35e-04 | 100 | 51 | 3 | 10048485 | ||
| Pubmed | 4.42e-04 | 242 | 51 | 4 | 34011540 | ||
| Pubmed | 4.78e-04 | 22 | 51 | 2 | 22187428 | ||
| Pubmed | 5.23e-04 | 23 | 51 | 2 | 20696395 | ||
| Pubmed | 5.23e-04 | 23 | 51 | 2 | 28811219 | ||
| Pubmed | 5.23e-04 | 23 | 51 | 2 | 9225980 | ||
| Pubmed | 5.30e-04 | 107 | 51 | 3 | 30995489 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.46e-04 | 256 | 51 | 4 | 33397691 | |
| Pubmed | 6.04e-04 | 263 | 51 | 4 | 34702444 | ||
| Pubmed | 6.15e-04 | 469 | 51 | 5 | 27634302 | ||
| Pubmed | DNA segments mapped by reciprocal use of microsatellite primers between mouse and rat. | 6.19e-04 | 25 | 51 | 2 | 8268655 | |
| Pubmed | Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms. | 6.19e-04 | 25 | 51 | 2 | 27340223 | |
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 6.19e-04 | 25 | 51 | 2 | 15820306 | |
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 6.70e-04 | 26 | 51 | 2 | 33905568 | |
| Pubmed | 6.87e-04 | 117 | 51 | 3 | 22174793 | ||
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 7.04e-04 | 118 | 51 | 3 | 37105989 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 7.94e-04 | 283 | 51 | 4 | 30585729 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 7.94e-04 | 123 | 51 | 3 | 26912792 | |
| Pubmed | 8.35e-04 | 29 | 51 | 2 | 30228103 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.15e-04 | 774 | 51 | 6 | 15302935 | |
| Pubmed | 9.32e-04 | 130 | 51 | 3 | 12421765 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 1.12e-03 | 536 | 51 | 5 | 15840001 | |
| Pubmed | 1.14e-03 | 538 | 51 | 5 | 10512203 | ||
| Pubmed | 1.15e-03 | 34 | 51 | 2 | 23926254 | ||
| Pubmed | 1.16e-03 | 1116 | 51 | 7 | 31753913 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.27e-03 | 552 | 51 | 5 | 10737800 | |
| Pubmed | Heart neurons use clock genes to control myocyte proliferation. | 1.36e-03 | 37 | 51 | 2 | 34851661 | |
| Pubmed | Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse. | 1.43e-03 | 38 | 51 | 2 | 27930960 | |
| Interaction | PHF21A interactions | 1.22e-07 | 343 | 49 | 9 | int:PHF21A | |
| Interaction | GSK3A interactions | 1.46e-05 | 464 | 49 | 8 | int:GSK3A | |
| Interaction | FHL2 interactions | 4.52e-05 | 396 | 49 | 7 | int:FHL2 | |
| Interaction | MN1 interactions | 4.72e-05 | 29 | 49 | 3 | int:MN1 | |
| Interaction | POU2F1 interactions | 6.53e-05 | 175 | 49 | 5 | int:POU2F1 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.62e-05 | 25 | 36 | 3 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.38e-04 | 9 | 36 | 2 | 755 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 9.50e-04 | 23 | 36 | 2 | 523 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.70e-03 | 718 | 36 | 6 | 28 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 3.11e-06 | 467 | 51 | 8 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 4.05e-06 | 484 | 51 | 8 | MM999 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR SP4 FAM184A UBQLN2 ZNF354A KIF15 RBM27 IFT74 MACF1 POU2F1 CHD9 TLR7 CHD7 TOP2A | 4.40e-06 | 1459 | 50 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR SP4 FAM184A UBQLN2 ZNF354A KIF15 RBM27 IFT74 MACF1 POU2F1 CHD9 TLR7 TOP2A | 4.67e-06 | 1257 | 50 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#1 | 2.49e-05 | 72 | 50 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 8.35e-05 | 98 | 50 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 1.14e-04 | 327 | 50 | 6 | GSM538380_500 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.17e-06 | 162 | 51 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 2.30e-06 | 186 | 51 | 5 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.49e-06 | 189 | 51 | 5 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.98e-06 | 196 | 51 | 5 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.74e-05 | 135 | 51 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.69e-05 | 151 | 51 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.06e-05 | 156 | 51 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 15-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 4.48e-05 | 172 | 51 | 4 | 36f2444754f1e37683cb812380e6b05b356f9f4a | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 176 | 51 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.90e-05 | 176 | 51 | 4 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 182 | 51 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 182 | 51 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.82e-05 | 184 | 51 | 4 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.07e-05 | 186 | 51 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.59e-05 | 190 | 51 | 4 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 6.59e-05 | 190 | 51 | 4 | 5624f711b34132081f93fa70702316962e3e3c64 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-05 | 191 | 51 | 4 | ff2cc4c10aa584b3daeaaf23cd8ee09bdbdf684d | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.73e-05 | 191 | 51 | 4 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.87e-05 | 192 | 51 | 4 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.87e-05 | 192 | 51 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 51 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 7.01e-05 | 193 | 51 | 4 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.01e-05 | 193 | 51 | 4 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 194 | 51 | 4 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 7.15e-05 | 194 | 51 | 4 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | mild-dn_T|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.29e-05 | 195 | 51 | 4 | 158f0f229bad71cc9b06b7399168982bbbbd1d47 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 7.58e-05 | 197 | 51 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.58e-05 | 197 | 51 | 4 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 7.58e-05 | 197 | 51 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.58e-05 | 197 | 51 | 4 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 7.89e-05 | 199 | 51 | 4 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.89e-05 | 199 | 51 | 4 | 53b3d35767889a152f1f38e8f6f0ba8f7a7690f2 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-04 | 101 | 51 | 3 | 657d3994b93e2fbb1ff96f701ff2ea6665e5a15c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.72e-04 | 110 | 51 | 3 | 0b39f3c358715e6e7288d3e4a0f3e7c0e877333c | |
| ToppCell | (05)_Ciliated-(3)_72hpi|(05)_Ciliated / shred by cell type and Timepoint | 2.94e-04 | 113 | 51 | 3 | eaa5bc8f8183b353ee1e7618e99220eb3684cd60 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.60e-04 | 121 | 51 | 3 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-04 | 126 | 51 | 3 | 197d2c836ae46a5c67f68d10c71ba86b7b40b59d | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-04 | 128 | 51 | 3 | c2045f052cc713e52312eb015825711576fcb6c5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.54e-04 | 131 | 51 | 3 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.64e-04 | 132 | 51 | 3 | 48449e2e95804a26f204ac7ea763dee26cf794ab | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-04 | 141 | 51 | 3 | d3ce2218bfa9750795d920e1ef162ea44efb2e66 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.74e-04 | 142 | 51 | 3 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 148 | 51 | 3 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.60e-04 | 149 | 51 | 3 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 6.60e-04 | 149 | 51 | 3 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.60e-04 | 149 | 51 | 3 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.26e-04 | 154 | 51 | 3 | a90c4c45685eae8d21d03479cfd5a23f6ed3ca07 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.40e-04 | 155 | 51 | 3 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.54e-04 | 156 | 51 | 3 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.54e-04 | 156 | 51 | 3 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.54e-04 | 156 | 51 | 3 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.54e-04 | 156 | 51 | 3 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-04 | 158 | 51 | 3 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-04 | 158 | 51 | 3 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.96e-04 | 159 | 51 | 3 | 0fbfdb18b7ed4bde077add13f2b3636e144b254f | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 8.11e-04 | 160 | 51 | 3 | 5744cd30709f38e84f7ec8893dc19d7a288b465a | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 8.11e-04 | 160 | 51 | 3 | 9f7f24a52a24fb926df69c8e5aad64ee75a66ef1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-04 | 160 | 51 | 3 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-04 | 162 | 51 | 3 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.56e-04 | 163 | 51 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.56e-04 | 163 | 51 | 3 | aa5ea367f787c1543afb7eb80a801432e1c44011 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.71e-04 | 164 | 51 | 3 | d5bb57c321f2973836efc8990449494cc1fb87c7 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.71e-04 | 164 | 51 | 3 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.86e-04 | 165 | 51 | 3 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.86e-04 | 165 | 51 | 3 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | Dividing_Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 9.02e-04 | 166 | 51 | 3 | ea95b94ccc2ac67df741b30c27f4ae698925875f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-04 | 167 | 51 | 3 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.18e-04 | 167 | 51 | 3 | 9280558baddea51aae47f3383d895a9b0c6749a4 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-04 | 167 | 51 | 3 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.18e-04 | 167 | 51 | 3 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 9.18e-04 | 167 | 51 | 3 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.18e-04 | 167 | 51 | 3 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.18e-04 | 167 | 51 | 3 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 9.34e-04 | 168 | 51 | 3 | 76b49463895cdef27c90f831c6246bcb92b9761b | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.34e-04 | 168 | 51 | 3 | 53a982869dbf14f6a948589be9f2f3df3b9a7e97 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.34e-04 | 168 | 51 | 3 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-04 | 169 | 51 | 3 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 9.50e-04 | 169 | 51 | 3 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-04 | 169 | 51 | 3 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-04 | 169 | 51 | 3 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.50e-04 | 169 | 51 | 3 | 17568e7aacfdcd96c469bae57d5ffad04954e9bd | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 9.50e-04 | 169 | 51 | 3 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.50e-04 | 169 | 51 | 3 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.50e-04 | 169 | 51 | 3 | 481e611b5fface58f1630f206c0b04fb54e24011 | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.50e-04 | 169 | 51 | 3 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 9.66e-04 | 170 | 51 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.66e-04 | 170 | 51 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.66e-04 | 170 | 51 | 3 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.66e-04 | 170 | 51 | 3 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.66e-04 | 170 | 51 | 3 | a7184dc41f90caa753860ed0f65a18133f84bc5f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-04 | 170 | 51 | 3 | 21bfe070e63722672176052b386167ea4c3dc4e5 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.66e-04 | 170 | 51 | 3 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.66e-04 | 170 | 51 | 3 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.83e-04 | 171 | 51 | 3 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.83e-04 | 171 | 51 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.83e-04 | 171 | 51 | 3 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 9.83e-04 | 171 | 51 | 3 | 0d14bc9688c427ba2265984987dc3eea195b19eb | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.99e-04 | 172 | 51 | 3 | ba36581ae339191a12a6d3ead39eaf69d78be10e | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.99e-04 | 172 | 51 | 3 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-04 | 172 | 51 | 3 | 1565f38266891c3acf49778838de134c5dee5460 | |
| Disease | prostate carcinoma | 1.65e-05 | 891 | 50 | 9 | EFO_0001663 | |
| Disease | Thyroid Dyshormonogenesis 1 | 4.20e-05 | 6 | 50 | 2 | C1848805 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.88e-05 | 7 | 50 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Goiter | 5.88e-05 | 7 | 50 | 2 | C0018021 | |
| Disease | cortical surface area measurement | 7.26e-05 | 1345 | 50 | 10 | EFO_0010736 | |
| Disease | Congenital Hypothyroidism | 2.17e-04 | 13 | 50 | 2 | C0010308 | |
| Disease | hypothyroidism (implicated_via_orthology) | 2.17e-04 | 13 | 50 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.53e-04 | 14 | 50 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | grip strength measurement | 3.12e-04 | 350 | 50 | 5 | EFO_0006941 | |
| Disease | neuroimaging measurement | 4.02e-04 | 1069 | 50 | 8 | EFO_0004346 | |
| Disease | systemic scleroderma | 4.10e-04 | 85 | 50 | 3 | EFO_0000717 | |
| Disease | corpus callosum mid-anterior volume measurement | 9.61e-04 | 27 | 50 | 2 | EFO_0010297 | |
| Disease | Liver carcinoma | 1.65e-03 | 507 | 50 | 5 | C2239176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LALTQQEQQQQPLTL | 936 | P41180 | |
| LANIAILNNNLNTLI | 91 | P20036 | |
| QQKLNCQIQQTTLQL | 351 | A2RUS2 | |
| QLLDAIQQKLNLSQQ | 501 | Q6ZP65 | |
| TSLQNLQNLQSLQLA | 2756 | Q9P2D1 | |
| IQLSQSQTSLQQLQA | 706 | Q8NB25 | |
| LQSSAQLLLQQQQTL | 681 | Q9P2N5 | |
| QLLLQQQQTLSHLSQ | 686 | Q9P2N5 | |
| FQVDNNNLLLLQQIS | 1296 | P20742 | |
| LNDLQQLNLSGNNLT | 696 | A4D1F6 | |
| QLINLQNLDLSFNQL | 131 | O43300 | |
| AQLLQIQTELNNSKQ | 586 | Q9NS87 | |
| QLTQQLQSLIPNNNV | 1476 | A6NM11 | |
| QLTQQLQSLIPNNNV | 1476 | A6NMS7 | |
| QLSNLSALLQQQDQK | 681 | Q8IX03 | |
| QLQPLQQVNLILSNN | 686 | Q9NRD8 | |
| NNEQPNSILTNNLQL | 3731 | Q5CZC0 | |
| LQQDTSVLQGNLQNQ | 181 | Q5KU26 | |
| GASLLLLQQQQQQQQ | 51 | P10275 | |
| ASQQNQQLETQLSLV | 481 | A6NDN3 | |
| LQEQAQTLQQQISSN | 746 | O94916 | |
| NSVSQLQNTIQQLQA | 766 | O94916 | |
| QQNTELQALLQQYLN | 706 | Q96MC2 | |
| QQQQLFLQLQILSQQ | 291 | Q8IZQ8 | |
| ANQLQQLQSQLAHQT | 1526 | Q9UPN3 | |
| LLLQQAQAQAQLLAA | 121 | P14859 | |
| AQNLLTQLPQQSQAN | 221 | P14859 | |
| TQLPQQSQANLLQSQ | 226 | P14859 | |
| TLQALQQNLQNLQSL | 2671 | Q3L8U1 | |
| QQNLQNLQSLQVTAG | 2676 | Q3L8U1 | |
| LTSLLQNNVNVNAQN | 21 | P42773 | |
| LQELDTLQQQLDSQN | 241 | Q96LB3 | |
| QQPLQSEQQLAQLTQ | 101 | Q8WV48 | |
| SEQQLAQLTQQLAQT | 106 | Q8WV48 | |
| AALSSQQQQQLALLL | 646 | Q6Y7W6 | |
| QQQQQLALLLQQFQT | 651 | Q6Y7W6 | |
| QQSNGSQTQLLQNFL | 271 | Q13322 | |
| LLNLDKTLNQLQQAQ | 1566 | A4D0S4 | |
| TLLQENNLQNAKTSQ | 726 | Q8NG08 | |
| VTSLELLNLNNNDIQ | 231 | A6NM36 | |
| NIQSLSNLQVQNAGL | 476 | Q02446 | |
| SNLQVQNAGLSQQLT | 481 | Q02446 | |
| IQNSQLQLQLNQDLS | 236 | P55347 | |
| LQNLQATSSLNSQLQ | 166 | P78424 | |
| ATSSLNSQLQQLQLQ | 171 | P78424 | |
| TQLDQNLLNSENLNN | 606 | Q8WYL5 | |
| LQGLLQNQSLQLQEQ | 416 | Q9Y228 | |
| QNQSLQLQEQEKLLT | 421 | Q9Y228 | |
| LANNNLQILNINKSD | 166 | O15394 | |
| NASLTNNQNLIQSLK | 1386 | P12270 | |
| ASGQNISQQALQNLQ | 426 | Q02447 | |
| ISQQALQNLQLQLNP | 431 | Q02447 | |
| NNLNQLQILDLSGNC | 246 | Q9NYK1 | |
| TQQPEQLQNLILSAQ | 596 | O43167 | |
| LAQNFVGSNNLNLLQ | 771 | P11388 | |
| LLEQQQAQLQQQLLL | 266 | P0CG23 | |
| QQTLQQGNLLAQQLT | 1396 | Q9UL36 | |
| IQGNSLKQNSQLLNQ | 191 | O60765 | |
| SLLQQITENPQLIQN | 371 | Q9UHD9 | |
| LNQVIVNGNQSLSSQ | 1861 | P01266 | |
| LNQLSQLNQLSQISQ | 1401 | Q8NDV7 | |
| QLNQLSQISQLQRLL | 1406 | Q8NDV7 | |
| ACQLLLQQQQQQQLL | 1281 | Q9UPQ9 |